These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4046761)

  • 21. The DES problem: fashioning a physician's duty to warn.
    Saber FA
    J Leg Med (N Y); 1977 Mar; 5(3):25-30. PubMed ID: 300422
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV, women, and access to clinical trials: tort liability and lessons from DES.
    Mastroianni AC
    Duke J Gend Law Policy; 1998; 5(1):167-91. PubMed ID: 11979601
    [No Abstract]   [Full Text] [Related]  

  • 23. Notes on the package insert.
    JAMA; 1969 Feb; 207(7):1335-8. PubMed ID: 5818325
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 25. Orphan drugs: the question of products liability.
    Scharf SF
    Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug legislation. Drug companies divided.
    Gershon D
    Nature; 1990 May; 345(6270):6. PubMed ID: 2330052
    [No Abstract]   [Full Text] [Related]  

  • 27. Under attack.
    Mod Vet Pract; 1981 Feb; 62(2):97-101. PubMed ID: 7254190
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical costs and the drug industry.
    Schwartz H
    Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081
    [No Abstract]   [Full Text] [Related]  

  • 29. Statutory compensation urged.
    Nature; 1985 Aug 8-14; 316(6028):476-7. PubMed ID: 4033748
    [No Abstract]   [Full Text] [Related]  

  • 30. A lawyer's autopsy on our dead drug laws.
    Cullen JP
    Minn Med; 1973 Mar; 56(3):223-36. PubMed ID: 4734618
    [No Abstract]   [Full Text] [Related]  

  • 31. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogens in beefsteaks.
    Jukes TH
    JAMA; 1974 Sep; 229(14):1920-1. PubMed ID: 4479122
    [No Abstract]   [Full Text] [Related]  

  • 33. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 34. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug shortage crisis resolution.
    Duffy E
    J Pharm Pract; 2012 Dec; 25(6):619-20. PubMed ID: 23222856
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety, supply, and suits--litigation and the vaccine industry.
    Kesselheim A
    N Engl J Med; 2011 Apr; 364(16):1485-7. PubMed ID: 21506740
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotechnology eclipsed?
    Nature; 1990 Feb; 343(6258):494. PubMed ID: 2300192
    [No Abstract]   [Full Text] [Related]  

  • 38. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
    Levy E
    Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigational exemption procedures for new drugs.
    Simmons HE
    JAMA; 1970 Sep; 213(11):1902-4. PubMed ID: 4917639
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives. Orphan Drug Act stumps lawmakers.
    Firshein J
    Faulkner Grays Med Health; 1990 Jun; 44(25):suppl 4 p.. PubMed ID: 10105023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.